Search Browse Earnings

Serina Therapeutics, Inc.

NYSE:SER

Pharmaceutical Preparations·HUNTSVILLE, AL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Serina Therapeutics, Inc. — SlamSEC

Revenue

$3.2M

+9173.5% YoY

FY 2024

Adj. EBITDA

-$3.0M

-96.4% margin

FY 2024

Net Income

$5.3M

167.1% margin

FY 2024

EPS (Diluted)

$0.73

FY 2024

Stock Price

$1.53

-2.5%

2026-03-06

52W Range

$1.47 – $7.92

P/E Ratio

2.1x

Market Cap

$16.3M

Cash

$7.6M

FY 2024

Total Debt

$13.2M

FY 2022

Net Debt

$5.6M

FY 2022

Enterprise Value

$21.9M

Debt / EBITDA

-1.8x

FY 2024

EV / EBITDA

-7.2x

Employees

—

CEO

Ledger Steven A